Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Solid Biosciences Inc.
NASDAQ:SLDBHealthcare · Biotechnology
-2.97%$6.20
AH$6.25+0.81%vs close
Mkt Cap$664.8M
Float69.29M
O/S107.23M
Vol
$ Vol
RVOL
Inst Own-
SI17.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$174.32M
Total Assets$232.54M
Free Cash Flow-$157.44M
Debt & Equity
Debt 11%
Equity 89%
Total Debt$21.16M
Total Equity$180.01M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:15Reverse splitOct 28, 202215 shares → 1
Balance Sheet Details
Assets$232.54M
Liabilities$52.53M
Accounts Receivable$0
Accounts Payable$3.22M
Inventory$0
PP&E (Net)$26.09M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $0 | $0 | $0 | $8.09M | $13.62M | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | -40.6% | - | - | - | - | - | - | - |
| Cost of Revenue | $1.64M | $2.46M | $2.58M | $0 | $0 | $3.92M | $2.82M | $1.57M | $0 | $56K | $0 |
| Gross Profit | -$1.64M | -$2.46M | -$2.58M | $8.09M | $13.62M | -$3.92M | -$2.82M | -$1.57M | -$448K | -$56K | $0 |
| Gross Margin | - | - | - | 100.0% | 100.0% | - | - | - | - | - | - |
| Research and Development | $140.32M | $96.43M | $76.56M | $78.42M | $58.74M | $64.88M | $94.74M | $57.97M | $39.91M | $20.12M | $4.19M |
| Selling, General, and Administrative | $38.88M | $33.3M | $27.75M | $28.95M | $27.14M | $21.58M | $24.58M | $17.72M | $14.95M | $5.46M | $2.37M |
| Other | -$1.64M | -$2.46M | -$2.58M | $7.18M | $0 | -$3.92M | $0 | $270K | $0 | $0 | $0 |
| Total Operating Expenses | $177.57M | $127.27M | $101.73M | $114.55M | $85.87M | $82.54M | $119.32M | $75.69M | $54.86M | $25.58M | $6.56M |
| Operating Income (EBIT) | -$179.21M | -$129.73M | -$104.31M | -$106.45M | -$72.25M | -$86.46M | -$119.32M | -$75.69M | -$54.86M | -$25.58M | -$6.56M |
| Operating Margin | - | - | - | -1315.2% | -530.5% | - | - | - | - | - | - |
| Interest Expense | $0 | $340K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $9.9M | $9.47M | $7.14M | $2.62M | $64K | $115K | $1.58M | $619K | $219K | $369K | $3K |
| Other Income (Expense) | $4.88M | $5.03M | $8.3M | $20.47M | $66K | -$1.83M | $2.1M | $889K | $1.68M | $1.8M | -$100K |
| Income Before Tax (EBT) | -$174.32M | -$124.7M | -$96.02M | -$85.98M | -$72.19M | -$88.29M | -$117.22M | -$74.8M | -$53.18M | -$23.77M | -$6.66M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$174.32M | -$124.7M | -$96.02M | -$85.98M | -$72.19M | -$88.29M | -$117.22M | -$74.8M | -$52.12M | -$21.54M | -$6.38M |
| Net Income Margin | - | - | - | -1062.3% | -530.0% | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 | -43.05 | -33.73 | -24.26 | -16.80 | -4.97 |
| Diluted EPS | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 | -43.05 | -33.73 | -24.26 | -16.80 | -4.97 |
| Weighted Average OS | 87.50M | 40.82M | 19.88M | 8.51M | 7.12M | 3.46M | 2.69M | 2.22M | 2.15M | 1.28M | 1.28M |
| EBITDA | -$172.69M | -$121.9M | -$93.43M | -$96.87M | -$69.22M | -$84.37M | -$116.49M | -$75.69M | -$54.41M | -$25.52M | -$100K |
| EBITDA Margin | - | - | - | -1196.8% | -508.3% | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $59.9M | $80.23M | $74.02M | $155.38M | $119.14M | $154.74M | $76.04M | $86.37M | $52.08M | $7.68M | $28.59M |
| Short-Term Investments | $127.95M | $68.69M | $49.63M | $58.34M | $88.64M | $0 | $7.48M | $36.1M | $17.01M | $29.98M | $26.79M |
| Cash and Short-Term Investments | $187.85M | $148.92M | $123.64M | $213.72M | $207.78M | $154.74M | $83.52M | $122.46M | $69.09M | $37.66M | $55.39M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $110K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3.64M | $1.65M | $2.11M | $3M | $8.71M | $1.48M | $1.49M | $1.81M | $613K | $235K | $88K |
| Total Current Assets | $205.46M | $157.3M | $129.73M | $219.64M | $222.61M | $158.9M | $86.3M | $128.64M | $70.66M | $39.97M | $55.7M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $26.09M | $29.04M | $33.16M | $38.61M | $7.6M | $11.73M | $16.63M | $10.42M | $2.43M | $452K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $991K | $2.32M | $2.04M | $2.01M | $2.16M | $536K | $536K | $536K | $3.11M | $212K | $0 |
| Total Long-Term Assets | $27.08M | $31.36M | $35.2M | $40.61M | $9.77M | $12.27M | $17.17M | $10.96M | $5.54M | $664K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $232.54M | $188.66M | $164.94M | $260.25M | $232.38M | $171.17M | $103.47M | $139.6M | $76.19M | $40.64M | $55.7M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $3.22M | $4.24M | $2.03M | $3.24M | $4.46M | $3.27M | $7.12M | $3.69M | $5.07M | $2.98M | $608K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $8.08M | $10.36M | $0 | $8.23M | $233K | $345K | $0 |
| Other Current Liabilities | $18.02M | $9.37M | $5.95M | $8.38M | $3.12M | $3.83M | $3.63M | -$3.15M | $4.17M | $2.38M | $13.06M |
| Total Current Liabilities | $33.47M | $30.26M | $14.52M | $22.51M | $23.6M | $24.48M | $18.28M | $12.48M | $11.27M | $6.87M | $13.92M |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $859K | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $10.36M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $96K | $0 | $1.3M | $0 | $215K | $0 | $71.65M | $61.7M |
| Total Long-Term Liabilities | $19.06M | $21.16M | $23.94M | $26.08M | $568K | $14.6M | $5.15M | $1.93M | $124.18M | $71.65M | $61.7M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $52.53M | $51.42M | $38.46M | $48.59M | $24.17M | $39.08M | $23.42M | $14.41M | $135.45M | $78.52M | $75.62M |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $124.18M | $71.65M | $61.7M |
| Common Stock | $79K | $40K | $20K | $20K | $7K | $87K | $48K | $35K | $65.01M | $558K | $208K |
| Retained Earnings | -$957.77M | -$783.45M | -$658.75M | -$562.74M | -$476.76M | -$404.57M | -$316.28M | -$199.06M | -$124.26M | -$84.94M | -$67.71M |
| Comprehensive Income & Other | $52K | $47K | $15K | -$68K | -$45K | $0 | $1K | -$5K | -$13K | $23K | -$10K |
| Other Stockholders' Equity | $1.14B | $920.66M | $785.21M | $774.38M | $684.96M | $536.57M | $396.28M | $324.2M | -$13K | $23K | -$10K |
| Total Equity | $180.01M | $137.25M | $126.48M | $211.67M | $208.21M | $132.09M | $80.05M | $125.18M | -$59.26M | -$84.36M | -$67.51M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $46.47M | $47.59M |
| Total Liabilities and Equity | $232.54M | $188.66M | $164.94M | $260.25M | $232.38M | $171.17M | $103.47M | $139.6M | $76.19M | -$5.84M | $8.11M |
| Supplementary Data | |||||||||||
| Total Debt | $21.16M | $24.18M | $26.27M | $28.55M | $2.06M | $5.15M | $7.07M | $1.89M | $0 | $0 | $0 |
| Net Debt | -$38.74M | -$56.06M | -$47.75M | -$126.84M | -$117.07M | -$149.59M | -$68.97M | -$84.47M | -$52.08M | -$7.68M | -$28.59M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$174.32M | -$124.7M | -$96.02M | -$85.98M | -$72.19M | -$88.29M | -$117.22M | -$74.8M | -$53.18M | -$23.77M | -$6.66M |
| Depreciation & Amortization | $1.64M | $2.46M | $2.58M | $2.41M | $2.96M | $3.92M | $2.82M | $1.57M | $448K | $56K | $6.56M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $1.21M | $0 | $0 | $0 | $206K | $505K | $0 |
| Stock-Based Compensation | $16.91M | $10.52M | $7.63M | $7.54M | $13.37M | $11.63M | $14.21M | $5.96M | $5.33M | $1.47M | $764K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $110K | -$110K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | -$11.5M | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$1.09M | $2.21M | -$764K | -$5.25M | $1.21M | -$3.43M | $3.78M | -$1.61M | $1.58M | $2.21M | $585K |
| Other Working Capital | -$5.73M | $645K | -$5.57M | $1.45M | -$12.64M | $19.59M | $3.98M | -$1.22M | $2.85M | $572K | $1M |
| Total Working Capital Change | -$6.82M | $2.85M | -$6.34M | -$3.69M | -$23.04M | $16.16M | $7.75M | -$2.83M | $4.43M | $2.79M | $1.59M |
| Other Non-Cash Items | $6.31M | $8.86M | -$2.03M | -$18.25M | -$81K | -$20K | -$277K | -$86K | -$459K | -$1.16M | -$6.46M |
| Net Cash from Operating | -$156.29M | -$100.01M | -$94.18M | -$97.98M | -$77.76M | -$56.6M | -$92.71M | -$70.2M | -$43.22M | -$20.12M | -$4.2M |
| Investing Activities | |||||||||||
| Capital Expenditures | -$1.15M | -$654K | -$1.51M | -$3.02M | -$1.28M | -$899K | -$4.39M | -$7.78M | -$2.28M | -$392K | $0 |
| Acquisitions | $85K | $5K | $0 | $31.52M | $89.81M | -$7.5M | -$24.52M | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$235.89M | -$204.34M | -$117.43M | -$182.76M | -$141.25M | -$401K | -$31.5M | -$44.32M | -$18.9M | -$25.7M | -$26.81M |
| Sales of Investments | $178.5M | $188.9M | $128.63M | $212.81M | $51.44M | $7.9M | $60.4M | $25.34M | $31.62M | $22.04M | $0 |
| Other Investing Activities | $0 | $0 | $0 | $600K | -$89.81M | $7.5M | $24.52M | -$18.99M | $100K | -$165K | -$26.81M |
| Net Cash from Investing | -$58.45M | -$16.09M | $9.69M | $59.16M | -$91.09M | $6.6M | $24.52M | -$26.76M | $10.55M | -$4.22M | -$26.81M |
| Financing Activities | |||||||||||
| Debt Repaid | $723K | $473K | - | -$2.08M | - | - | - | $13K | - | - | - |
| Common Stock Issuance | $194.74M | $127.23M | $2.97M | $72.55M | $134.88M | $132.49M | $49.33M | $133.69M | $79.5M | $3.42M | $51.59M |
| Common Stock Repurchases | $0 | -$5.11M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $425K | $794K | $148K | $203K | $107K | $0 | $8.55M | -$2.17M | -$2.42M | $0 | $44.75M |
| Net Cash from Financing | $194.45M | $122.44M | $3.12M | $74.83M | $134.99M | $128.7M | $57.88M | $131.51M | $77.08M | $3.42M | $51.59M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$20.3M | $6.34M | -$81.37M | $36.01M | -$33.87M | $78.7M | -$10.32M | $34.55M | $44.4M | -$20.92M | $20.58M |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$156.29M | -$100.01M | -$94.18M | -$97.98M | -$77.76M | -$56.6M | -$92.71M | -$70.2M | -$43.22M | -$20.12M | -$4.2M |
| Capital Expenditure | -$1.15M | -$654K | -$1.51M | -$3.02M | -$1.28M | -$899K | -$4.39M | -$7.78M | -$2.28M | -$392K | $0 |
| Free Cash Flow | -$157.44M | -$100.67M | -$95.69M | -$100.99M | -$79.05M | -$57.5M | -$97.1M | -$77.97M | -$45.5M | -$20.51M | -$4.2M |
| Cash at Beginning | $82.19M | $75.85M | $155.38M | $121.21M | $155.07M | $76.37M | $86.69M | $52.15M | $7.68M | $28.59M | $8.01M |
| Cash at End | $61.89M | $82.19M | $74.02M | $157.22M | $121.21M | $155.07M | $76.37M | $86.69M | $52.08M | $7.68M | $28.59M |